BB&T Securities’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BB&T Securities’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$352K	Hold	25,700	–	–	﹤0.01%	1251
2019 Q2	$316K	Sell	25,700 -1,400	-5%	-$16.2K	﹤0.01%	1294
2019 Q1	$338K	Buy	27,100 +3,300	+14%	+$44.1K	﹤0.01%	1242
2018 Q4	$269K	Sell	23,800 -3,500	-13%	-$54.9K	﹤0.01%	1227
2018 Q3	$510K	Hold	27,300	–	–	0.01%	1076
2018 Q2	$705K	Buy	27,300 +3,000	+12%	+$77.8K	0.01%	941
2018 Q1	$544K	Hold	24,300	–	–	0.01%	985
2017 Q4	$608K	Buy	24,300 +14,000	+136%	+$343K	0.01%	929
2017 Q3	$249K	Sell	10,300 -4,000	-28%	-$94K	﹤0.01%	1221
2017 Q2	$289K	Buy	+14,300	New	+$298K	﹤0.01%	1170

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BB&T Securities's FLXN Position: Q3 2019 in Review

BB&T Securities held its Flexion Therapeutics, Inc. (FLXN) position steady in Q3 2019 at 25,700 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

BB&T Securities first reported a position in FLXN in Q2 2017 and has held it in 10 quarters since. The position peaked at $705K in Q2 2018. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

BB&T Securities held 25,700 shares of Flexion Therapeutics, Inc. worth $352K as of Q3 2019.
BB&T Securities left its Flexion Therapeutics, Inc. share count unchanged in Q3 2019.
Flexion Therapeutics, Inc. made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1251 holding.
BB&T Securities first reported a position in Flexion Therapeutics, Inc. in Q2 2017 and has held it in 10 quarters since.
BB&T Securities's Flexion Therapeutics, Inc. position peaked at $705K in Q2 2018.
126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.